Walleye Capital’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$25.2M Buy
295,779
+294,311
+20,048% +$26.6M 0.02% 661
2026
Q2
$135K Sell
1,468
-86,540
-98% -$7.57M ﹤0.01% 3723
2026
Q1
$7.5M Buy
88,008
+86,383
+5,316% +$7.7M 0.03% 548
2025
Q4
$128K Sell
1,625
-2,181
-57% -$171K ﹤0.01% 3758
2025
Q3
$304K Sell
3,806
-1,593
-30% -$136K ﹤0.01% 2993
2025
Q2
$491K Buy
+5,399
New +$493K ﹤0.01% 2650
2025
Q1
– Sell
-1,452
Closed -$130K – 4347
2024
Q4
$132K Sell
1,452
-106,990
-99% -$10.2M ﹤0.01% 3997
2024
Q3
$11.3M Sell
108,442
-130,138
-55% -$13.3M 0.02% 627
2024
Q2
$23.2M Buy
+238,580
New +$22M 0.04% 307
2023
Q3
– Sell
-81,377
Closed -$6.08M – 4928
2023
Q2
$6.27M Buy
81,377
+73,953
+996% +$5.72M 0.02% 612
2023
Q1
$558K Sell
7,424
-3,899
-34% -$290K 0.01% 1617
2022
Q4
$892K Sell
11,323
-4,658
-29% -$349K 0.02% 1069
2022
Q3
$1.12M Sell
15,981
-3,838
-19% -$301K 0.02% 892
2022
Q2
$1.59M Buy
+19,819
New +$1.55M 0.04% 441
2022
Q1
– Sell
-2,508
Closed -$214K – 2324
2021
Q4
$214K Buy
+2,508
New +$196K 0.01% 1431

Other funds holding CL

Walleye Capital's CL Position: Q3 2026 in Review

Walleye Capital increased its Colgate-Palmolive (CL) stake by 20,048% in Q3 2026, buying an estimated $26.6M and bringing the position to 295,779 shares worth $25.2M. The position accounts for 0.02% of the portfolio, ranked #661.

Walleye Capital first reported a position in CL in Q4 2021 and has held it in 15 quarters since. 1,939 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Walleye Capital held 295,779 shares of Colgate-Palmolive worth $25.2M as of Q3 2026.
  • Walleye Capital bought 294,311 Colgate-Palmolive shares in Q3 2026, an estimated $26.6M.
  • Colgate-Palmolive made up 0.02% of Walleye Capital's portfolio in Q3 2026, its #661 holding.
  • Walleye Capital first reported a position in Colgate-Palmolive in Q4 2021 and has held it in 15 quarters since.
  • 1,939 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.